JPMorgan Chase & Co’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4
| Closed | -$1K | – | 5711 |
|
|
2022
Q1 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 5639 |
|
|
2020
Q2 | – | Sell |
-13
| Closed | -$8K | – | 4815 |
|
|
2020
Q1 | $8K | Sell |
13
-282
| -96% | -$174K | ﹤0.01% | 4476 |
|
|
2019
Q4 | $307K | Sell |
295
-47
| -14% | -$48.9K | ﹤0.01% | 3661 |
|
|
2019
Q3 | $294K | Buy |
342
+179
| +110% | +$154K | ﹤0.01% | 3574 |
|
|
2019
Q2 | $183K | Sell |
163
-42
| -20% | -$47.2K | ﹤0.01% | 3794 |
|
|
2019
Q1 | $302K | Buy |
205
+193
| +1,608% | +$284K | ﹤0.01% | 3593 |
|
|
2018
Q4 | $14K | Buy |
+12
| New | +$14K | ﹤0.01% | 4558 |
|
|
2018
Q2 | – | Sell |
-21
| Closed | -$21K | – | 4779 |
|
|
2018
Q1 | $21K | Sell |
21
-1
| -5% | -$1K | ﹤0.01% | 4404 |
|
|
2017
Q4 | $36K | Buy |
22
+19
| +633% | +$31.1K | ﹤0.01% | 4230 |
|
|
2017
Q3 | $5K | Buy |
+3
| New | +$5K | ﹤0.01% | 4127 |
|